Approved Symbol |
Approved Name |
Location |
Source |
ITGAL |
integrin, alpha L (antigen CD11A (p180), lymphocyte function-associated antigen 1; alpha polypeptide) |
16p13.1-p11 |
Mapped by CNV |
PRKCB |
protein kinase C, beta |
16p12 |
Mapped by significant region |
ACTN3 |
actinin, alpha 3 |
11q13-q14 |
Mapped by significant region |
CYBA |
cytochrome b-245, alpha polypeptide |
16q24 |
Mapped by significant region |
ESAM |
endothelial cell adhesion molecule |
11q24.2 |
Mapped by significant region |
CLDN5 |
claudin 5 |
22q11.21 |
Mapped by CNV |
NCF2 |
neutrophil cytosolic factor 2 |
1q25 |
Mapped by significant region |
THY1 |
Thy-1 cell surface antigen |
11q23.3 |
Mapped by significant region |
JAM3 |
junctional adhesion molecule 3 |
11q25 |
Mapped by significant region |
PIK3R1 |
phosphoinositide-3-kinase, regulatory subunit 1 (alpha) |
5q13.1 |
Mapped by significant region |
ITK |
IL2-inducible T-cell kinase |
5q31-q32 |
Mapped by significant region |
MYLPF |
myosin light chain, phosphorylatable, fast skeletal muscle |
16p11.2 |
Mapped by CNV |
CTNND1 |
catenin (cadherin-associated protein), delta 1 |
11q12.1 |
Mapped by significant region |
PIK3CG |
phosphoinositide-3-kinase, catalytic, gamma polypeptide |
7q22 |
Mapped by CNV |
SIPA1 |
signal-induced proliferation-associated 1 |
11q13.3 |
Mapped by significant region |
CTNNA3 |
catenin (cadherin-associated protein), alpha 3 |
10q21 |
Mapped by CNV |
CXCL12 |
chemokine (C-X-C motif) ligand 12 |
10q11.1 |
Mapped by PBA pathway |
ARHGAP5 |
Rho GTPase activating protein 5 |
14q12 |
Mapped by significant region |
BCAR1 |
breast cancer anti-estrogen resistance 1 |
16q22-q23 |
Mapped by significant region |
PLCG2 |
phospholipase C, gamma 2 (phosphatidylinositol-specific) |
16q24.1 |
Mapped by significant region |
ROCK2 |
Rho-associated, coiled-coil containing protein kinase 2 |
2p24 |
Mapped by significant region |